GIP/GLP-1
Sort by:
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
- 7,798 views
- August 14, 2023
- 114
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
- 2,202 views
- January 26, 2024
- 40
Scripps Health
Medications for Weight Loss: The New Satiety Hormones
FEATURING
Ken Fujioka
- 15,008 views
- November 28, 2022
- 73
ACC 2023 Conference Coverage
ACC 2023: Failure to Treat With Pharmacologic GDMT After an MI: Opportunities Lost
FEATURING
Vicki Groo
- 1,345 views
- April 3, 2023
- 4
UT Health San Antonio School of Medicine
Effective Treatment of T2DM Requires Combination Therapy
FEATURING
Ralph DeFronzo
- 2,511 views
- August 30, 2023
- 20
Scripps Health
Obesity Treatment: The Essentials (2024 Update)
FEATURING
Samantha Harris
- 931 views
- April 30, 2024
- 15
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
FEATURING
Steven Nissen
- 5,636 views
- July 26, 2023
- 61
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
- 2,136 views
- January 29, 2024
- 37
Diana Isaacs
Clinical Pearls & Updates on Incretins: The Diabetes Drugs Taking Hollywood by Storm
- 3,387 views
- August 29, 2023
- 20
ADA 2023 Insights
ADA 2023 Insights: Role for Amylin in Monotherapy and Combination Therapy for Obesity
FEATURING
David Lau
- 1,373 views
- July 14, 2023
- 11
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 2
FEATURING
Eden Miller
- 2,604 views
- November 30, 2023
- 22
McMaster University Department of Medicine
Semaglutide: Where Are We Now and Where Are We Going?
- 4,169 views
- September 27, 2023
- 24
Houston Methodist Hospital
Obesity: Epidemiology and Medical Management in 2023
FEATURING
Archana Sadhu
- 1,368 views
- August 22, 2023
- 6